NHS National Framework for Transition products commencing 1 February 2025
Estimated value
—
Awarded value
—
Suppliers
6
Lots
1
Published
21 Jan 2025
Description
Project title: NHS National Framework for Transition products commencing 1 February 2025<br/>Offer reference number: CM/TNS/24/5713<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/><br/>CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection<br/><br/>Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months)<br/>Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)<br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England
Scope
- Reference
- CM/TNS/24/5713
- Commercial tool
- Standalone contract
- Contract dates
- 01 Feb 2025 to 31 May 2026
- Main category
- goods
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| — | — | price | — |
Submission & procedure
- Procedure
- Open procedure
Award details· 6 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—